Merck resolves Vytorin case for $688m
Tuesday, February 19, 2013 - 12:10
in Psychology & Sociology
Investors say the company knew about Enhance trial failure but withheld information
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via